MetLife, Inc. (MET) has a consensus analyst rating of Buy, based on 32 analysts covering the stock. Of those, 24 recommend buying, 8 recommend holding, and 0 recommend selling.
The analyst consensus price target for MET is $96.83, representing a +27.3% upside from the current price of $76.04. Price targets range from a low of $90.00 to a high of $101.00.
